TGR-1202 (Umbralisib) in Treatment Na ïve Patients With Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia Intervention: Drug: Umbralisib Sponsors: H. Lee Moffitt Cancer Center and Research Institute; TG Therapeutics, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Leukemia | Research